NASDAQ •
Healthcare •
Drug Manufacturers - General •
Quote as of 09/02/2026 16:00
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization296.78 mln
Float20.73 mln
Earnings Date11/04/2026
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-3.19
Reliable
Relative Strength
23
/ 100
Significantly lagging
Debt / Equity
0.01
Debt-free
Pre-Tax Margin
-14%
Loss-making
ROE
-5.96
Negative
Business Description
Amarin Corporation plc is an Ireland-based pharmaceutical company focused on developing and selling treatments for heart and cardiovascular conditions across the United States, Europe, and other markets. Its main product, VASCEPA, is a prescription omega-3 medication that helps lower dangerously high triglyceride levels in adult patients when used alongside a controlled diet. The company distributes its products through wholesale and retail pharmacy networks, and works with Japan's Mochida Pharmaceutical to expand the use of VASCEPA's key active ingredient in new treatments. Founded in 1989 and originally known as Ethical Holdings plc, the company adopted its current name in 1999.
